Home » Archive

Xconomy

News, Syndication, Xconomy »

How the TCA is Making 2013 The Year of the Angel Investor

Posted by sandiegobiotech January 17th, 2013 .
No Comments

A number of pundits have been claiming that angel investment is waning, and that such funding opportunities will remain few and far between for deserving startups seeking to take their innovations to…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Sanford-Burnham’s CEO Sees Incredible Opportunity in Move to Roche

Posted by sandiegobiotech January 16th, 2013 .
No Comments

John Reed says his decision to resign as CEO of Sanford-Burnham Medical Research Institute was not planned—but came about with an offer to join the Swiss pharmaceutical giant—and he cited both…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Roche Recruits Sanford-Burnham CEO John Reed to Head Pharma Research

Posted by sandiegobiotech January 15th, 2013 .
No Comments

John Reed, who led San Diego’s Sanford-Burnham Medical Research Institute during a period of extraordinary growth, has resigned as CEO to become the head of pharmaceutical research and early…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

If You’ve Got a Real Breakthrough, the FDA Wants To Talk

Posted by sandiegobiotech January 14th, 2013 .
No Comments

If you ever want to have an interesting chat with a healthcare journalist, ask about use of the word “breakthrough.” Like many reporters, I generally avoid it. The word may be good for generating…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

‘Small Ball’ Investing as an Alternative Model in Life Sciences

Posted by sandiegobiotech January 9th, 2013 .
No Comments

The phrase “the VC model is broken” has become cliché over the past few years. Many theories on why this is the case have been posed, including Sequoia Capital’s Douglas Leone, who told a VC…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

After Clinical Trial Setback, San Diego’s MediciNova Sets New Course

Posted by sandiegobiotech January 8th, 2013 .
No Comments

MediciNova (NASDAQ: MNOV) didn’t have much of a fallback strategy last May, when the San Diego biotech reported that a mid-stage trial of bedoradrine sulfate for intravenous treatment of acute asthma…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

PatientSafe Raises $20M to Push Market Adoption of Health IT Device

Posted by sandiegobiotech January 7th, 2013 .
No Comments

San Diego’s PatientSafe Solutions, which developed a handheld smart device to improve nursing care, says today it has raised $20 million in a Series C round of financing led by the Merck Global…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Biotech CEOs See Insurers as the New Boogeymen, Not FDA

Posted by sandiegobiotech January 7th, 2013 .
No Comments

Most biotech executives would have said a few years ago that the FDA was the No. 1 barrier standing in the way of business success. It was the one thing they worried about most. But now biotech CEOs…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

My Report Card for JP Morgan Healthcare Conference Picks

Posted by sandiegobiotech January 7th, 2013 .
No Comments

Forecasting trends in an industry that you cover every day, if you take time to think about it, is not that hard. Checking back a year later to see how right you were? That can be a little…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Sialix Moves into SD’s Janssen Labs to Focus on Inflammatory Target

Posted by sandiegobiotech January 3rd, 2013 .
No Comments

Experts in nutrition science have long fretted about the correlation between diets that are rich in certain foods—such as red meat and dairy products—with an increased risk of heart attacks, cancer,…

[[Click headline to continue reading.]]

More...